Equillium Analyst Ratings
Novavax (NVAX) Was Upgraded to a Hold Rating at J.P. Morgan
Buy Rating Affirmed for Equillium on Milestones and Financial Prospects
Analysts Conflicted on These Healthcare Names: AstraZeneca (GB:AZN), Sartorius (GB:0NIR) and Caribou Biosciences (CRBU)
Johnson & Johnson Analyst Ratings
Analysts' Top Healthcare Picks: AstraZeneca (AZN), Aprea Therapeutics (APRE)
Johnson & Johnson (JNJ) Receives a Buy From RBC Capital
Ocugen Analyst Ratings
Buy Rating Affirmed for Ocugen on Strong Financials and Advancing Clinical Pipeline
Eli Lilly and Co Analyst Ratings
Analysts Are Bullish on Top Healthcare Stocks: Merck & Company (MRK), Inovio Pharmaceuticals (INO)
Argus Adjusts Price Target on Eli Lilly to $840 From $770
Evercore ISI Starts BioNTech With In Line Rating, $100 Price Target
Redburn Atlantic Adjusts Eli Lilly Price Target to $600 From $540
Inovio Pharmaceuticals: Hold Rating Amidst Clinical Progress and Financial Caution
Inovio Pharmaceuticals Analyst Ratings
Veru Analyst Ratings
Moderna Analyst Ratings
BioNTech Analyst Ratings
Buy Rating on Equillium as Promising Trials and Financial Stability Signal Upside Potential